AlphaCentric Advisors »

Cabaletta Bio shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 65k 17.06

More positions owned by AlphaCentric Advisors

Pfizer (PFE)
Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
United Therapeutics Corporation (UTHR)
Pacira Pharmaceuticals (PCRX)
BioCryst Pharmaceuticals (BCRX)
Galapagos Nv Spon Adr (GLPG)
Argenx Se Sponsored Adr (ARGX)
Two Harbors Inventment Corpo Note 6.250% 1/1
Inari Medical Ord (NARI)
Docgo (DCGO)
Beigene Sponsored Adr (BGNE)
Ellington Financial Inc ellington financ (EFC)
Axsome Therapeutics (AXSM)
MGIC Investment (MTG)

View all positions for AlphaCentric Advisors

Top funds holding Cabaletta Bio

Jennison Associates
Fred Alger Management
VR Adviser
Vanguard Group
Lynx1 Capital Management
Deerfield Management Company
Perceptive Advisors
Holocene Advisors
Commodore Capital
Redmile Group
Wellington Management Company
T. Rowe Price Associates
Ikarian Capital
Victory Capital Management
Blackstone Group

View all funds holding Cabaletta Bio